:

Wei Wu1, Nan Li2,3, Tingting Wang4

  • 1Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Advances in therapy
|May 29, 2025
PubMed
概括

在中国,重组人体生长激素 (rhGH) 治疗矮身 (SS) 患者的停药率很高,许多儿童开始治疗的时间较晚. 提高坚持和遵循指导方针对于儿童生长激素治疗的更好的结果至关重要.